DENVER, April 11, 2022 /CNW/ - Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), is pleased to announce that Justin Dye, Chairman & CEO and Nancy Huber, CFO will participate in the following conferences and events.

Cantor Fitzgerald 2nd Annual Virtual Cannabis Conference - April 12-14, 2022 
Justin Dye, Chairman & CEO is scheduled to participate in a panel discussion entitled, "Emerging MSOs" on Tuesday, April 12 at 1:50 pm ET.  Management will also be participating in one-on-one investor meetings throughout the conference. For more information, please contact your Cantor Fitzgerald representative. 

NobleCon 18, Hard Rock Casino & Hotel – April 19-21, 2022
Justin Dye, Chairman & CEO is scheduled to present at NobleCon18 - Noble Capital Markets' Eighteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida, on Thursday April 21, at 11:00 am ET in the Seminole Ballroom A.  Management will also be participating in one-on-one investor meetings throughout the event. For more information, please contact your Noble Capital representative. 

VID Forum – 11:00 am ET – Live Town Hall – April 26, 2022
Justin Dye, Chairman & CEO will present to investors in a live VID Forum Town Hall.  Management will field Q&A from investors and interested parties after their presentation. Please sign up here to register.

A.G.P.'s Spring Virtual Consumer Cannabis Conference – May 3, 2022
Management will be participating in one-on-one investor meetings throughout the Conference. For more information, please contact your A.G.P. representative. 

About Schwazze
Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position.  Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.  The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition.  Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes.  The Company's leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.  Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.  Medicine Man Technologies, Inc. was Schwazze's former operating trade name.  The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements
This press release contains "forward-looking statements." Such statements may be preceded by the words "plan," "will," "may,", "predicts," or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and * out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Cision View original content to download multimedia:

SOURCE Medicine Man Technologies, Inc.